Literature DB >> 19436461

Do childhood vaccines cause thrombocytopenia?

Laura J Sauvé1, David Scheifele.   

Abstract

Entities:  

Year:  2009        PMID： 19436461      PMCID： PMC2661332          DOI： 10.1093/pch/14.1.31

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN： 1205-7088            Impact factor:   2.253


× No keyword cloud information.
  8 in total

1.  MMR vaccine and idiopathic thrombocytopaenic purpura.

Authors:  Corri Black; James A Kaye; Hershel Jick
Journal:  Br J Clin Pharmacol       Date:  2003-01       Impact factor: 4.335

2.  Idiopathic thrombocytopenic purpura and the second dose of MMR.

Authors:  Julia Stowe; George Kafatos; Nick Andrews; Elizabeth Miller
Journal:  Arch Dis Child       Date:  2007-10-25       Impact factor: 3.791

3.  Thrombocytopenia after immunization with measles vaccines: review of the vaccine adverse events reporting system (1990 to 1994).

Authors:  J Beeler; F Varricchio; R Wise
Journal:  Pediatr Infect Dis J       Date:  1996-01       Impact factor: 2.129

4.  Idiopathic thrombocytopenic purpura and MMR vaccine.

Authors:  E Miller; P Waight; C P Farrington; N Andrews; J Stowe; B Taylor
Journal:  Arch Dis Child       Date:  2001-03       Impact factor: 3.791

5.  Recurrent thrombocytopenic purpura after repeated measles-mumps-rubella vaccination.

Authors:  V Vlacha; E N Forman; D Miron; G Peter
Journal:  Pediatrics       Date:  1996-05       Impact factor: 7.124

6.  Thrombocytopenia after immunization of Canadian children, 1992 to 2001.

Authors:  Taj Jadavji; David Scheifele; Scott Halperin
Journal:  Pediatr Infect Dis J       Date:  2003-02       Impact factor: 2.129

7.  Thrombocytopenic purpura after measles, mumps and rubella vaccination: a retrospective survey by the French regional pharmacovigilance centres and pasteur-mérieux sérums et vaccins.

Authors:  A P Jonville-Béra; E Autret; C Galy-Eyraud; L Hessel
Journal:  Pediatr Infect Dis J       Date:  1996-01       Impact factor: 2.129

8.  Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children.

Authors:  Eric K France; Jason Glanz; Stanley Xu; Simon Hambidge; Kristi Yamasaki; Steve B Black; Michael Marcy; John P Mullooly; Lisa A Jackson; James Nordin; Edward A Belongia; K Hohman; Robert T Chen; Robert Davis
Journal:  Pediatrics       Date:  2008-03       Impact factor: 7.124
  8 in total
  5 in total

Review 1.  Vaccine administration and the development of immune thrombocytopenic purpura in children.

Authors:  Valerio Cecinati; Nicola Principi; Letizia Brescia; Paola Giordano; Susanna Esposito
Journal:  Hum Vaccin Immunother       Date:  2013-01-16       Impact factor: 3.452

2.  The Canadian Immunization Monitoring Program, ACTive (IMPACT): Active surveillance for vaccine adverse events and vaccine-preventable diseases.

Authors:  J A Bettinger; S A Halperin; W Vaudry; B J Law; D W Scheifele
Journal:  Can Commun Dis Rep       Date:  2014-12-04

Review 3.  The clinical correlates of vaccine-induced immune thrombotic thrombocytopenia after immunisation with adenovirus vector-based SARS-CoV-2 vaccines.

Authors:  Eleanor R Gaunt; Neil A Mabbott
Journal:  Immunother Adv       Date:  2021-08-17

Review 4.  Safety assessment of adjuvanted vaccines: Methodological considerations.

Authors:  Fernanda Tavares Da Silva; Alberta Di Pasquale; Juan P Yarzabal; Nathalie Garçon
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 5.  Frequently asked questions on seven rare adverse events following immunization.

Authors:  G L D'alò; E Zorzoli; A Capanna; G Gervasi; E Terracciano; L Zaratti; E Franco
Journal:  J Prev Med Hyg       Date:  2017-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.